Perphenazine: Clinical Trials

5 trials of Perphenazine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 unknown. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Terminated 1, Unknown 1

Follow Perphenazine: new trials by email Literature Review of Perphenazine trials Research Report on Perphenazine

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data
Neuraxial Analgesia, Regional Block 1: Paravertebral, Perphenazine - Perioperative Optimization
Phase 3CompletedJennifer Holder-Murray33952023-05-152026-05-28
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
Aripiprazole, Haloperidol, Olanzapine - Schizophrenia, Psychotic Disorders
Phase 3CompletedJanssen Scientific Affairs, LLC3372015-07-082025-04-29
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28
Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
Discontinuation antipsychotic treatment, Antipsychotic treatment - Psychosis Nos/Other
Phase 3UnknownFundación Pública Andaluza Progreso y Salud1042012-11-012014-12-05
Serotonergic Pharmacotherapy for Agitation of Dementia
Citalopram [Celexa], Perphenazine [Trilafon] - Dementia, Alzheimer Disease
Phase 3CompletedBruce Pollock1995-09-012017-06-16

Conditions studied

Dementia (2)  ·  Schizophrenia (2)  ·  Alzheimer Disease (1)  ·  Anxiety Disorders (1)  ·  Dementia, Vascular (1)  ·  Depression (1)  ·  Postoperative Nausea and Vomiting (1)  ·  Problem Behavior (1)  ·  Psychomotor Agitation (1)  ·  Psychophysiologic Disorders (1)  ·  Psychotic Disorders (1)

Sponsors

Bruce Pollock (1)  ·  Fundación Pública Andaluza Progreso y Salud (1)  ·  Hannover Medical School (1)  ·  Janssen Scientific Affairs, LLC (1)  ·  Jennifer Holder-Murray (1)

Countries

United States (3)  ·  Brazil (1)  ·  Germany (1)  ·  Mexico (1)  ·  Spain (1)

Top investigators

Bruce G. Pollock, M.D., Ph.D. (1)  ·  Helge Frieling, Prof., MD (1)  ·  Miguel Ruiz Veguilla, MD, PhD (1)  ·  Stephen Esper, MD, MBA (1)

Results publications

PMID 35247794, PMID 35939921, PMID 37004331, PMID 37756123, PMID 38154902

NIH funding

R01MH059666 (1)